Annotation (Toggle Detail/Summary View) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene-Chemical Interaction Annotations
Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 17alpha-ethynylestradiol | affects expression | ISO | RGD:736461 | 6480464 | Ethinyl Estradiol affects the expression of ALOX5AP mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:2097 | 6480464 | Ethinyl Estradiol affects the expression of ALOX5AP mRNA | CTD | PMID:16079270 | 17alpha-ethynylestradiol | increases expression | ISO | RGD:736461 | 6480464 | Ethinyl Estradiol results in increased expression of ALOX5AP mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALOX5AP mRNA] | CTD | PMID:11007951 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:736461 | 6480464 | Tetrachlorodibenzodioxin affects the expression of ALOX5AP mRNA | CTD | PMID:21570461 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of ALOX5AP mRNA | CTD | PMID:11007951 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of ALOX5AP mRNA | CTD | PMID:18762178 | 4-hydroxynon-2-enal | increases expression | ISO | RGD:736461 | 6480464 | 4-hydroxy-2-nonenal results in increased expression of ALOX5AP mRNA | CTD | PMID:19191707 | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of ALOX5AP mRNA | CTD | PMID:21641981 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ALOX5AP mRNA | CTD | PMID:17218384 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ALOX5AP mRNA | CTD | PMID:15498508 more ... | all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ALOX5AP mRNA | CTD | PMID:15894607 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ALOX5AP mRNA | CTD | PMID:15498508 PMID:17218384 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of ALOX5AP mRNA | CTD | PMID:17218384 PMID:15498508 | ammonium chloride | affects expression | ISO | RGD:2097 | 6480464 | Ammonium Chloride affects the expression of ALOX5AP mRNA | CTD | PMID:16483693 | benzo[a]pyrene | multiple interactions | ISO | RGD:736461 | 6480464 | AHR protein affects the reaction [Benzo(a)pyrene affects the expression of ALOX5AP mRNA] | CTD | PMID:22228805 | benzo[a]pyrene | increases expression | ISO | RGD:736461 | 6480464 | Benzo(a)pyrene results in increased expression of ALOX5AP mRNA | CTD | PMID:22228805 | cadmium dichloride | decreases methylation | ISO | RGD:2097 | 6480464 | Cadmium Chloride results in decreased methylation of ALOX5AP promoter | CTD | PMID:22457795 | choline | multiple interactions | ISO | RGD:736461 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALOX5AP mRNA | CTD | PMID:20938992 | cisplatin | increases expression | ISO | RGD:736461 | 6480464 | Cisplatin results in increased expression of ALOX5AP mRNA | CTD | PMID:15471895 PMID:15464296 | cisplatin | increases expression | ISO | RGD:736461 | 6480464 | Cisplatin results in increased expression of ALOX5AP mRNA | CTD | PMID:15464296 PMID:15471895 | cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of ALOX5AP mRNA] | CTD | PMID:11007951 | cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of ALOX5AP mRNA | CTD | PMID:17403535 | D-penicillamine | increases expression | ISO | RGD:2097 | 6480464 | Penicillamine results in increased expression of ALOX5AP mRNA | CTD | PMID:19575532 | diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of ALOX5AP mRNA | CTD | PMID:15070760 PMID:15761015 | diarsenic trioxide | multiple interactions | EXP | | 6480464 | [Tretinoin co-treated with arsenic trioxide] results in increased expression of ALOX5AP mRNA | CTD | PMID:15894607 | diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of ALOX5AP mRNA | CTD | PMID:15761015 PMID:15070760 | diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of ALOX5AP mRNA | CTD | PMID:19128835 | folic acid | multiple interactions | ISO | RGD:736461 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALOX5AP mRNA | CTD | PMID:20938992 | furan | increases methylation | ISO | RGD:2097 | 6480464 | furan results in increased methylation of ALOX5AP gene | CTD | PMID:22079235 | hexachlorobenzene | affects expression | ISO | RGD:2097 | 6480464 | Hexachlorobenzene affects the expression of ALOX5AP mRNA | CTD | PMID:15159207 | histamine | multiple interactions | EXP | | 6480464 | ALOX5AP protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]; more ... | CTD | PMID:9609743 | hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of ALOX5AP mRNA | CTD | PMID:15761015 | indinavir | multiple interactions | ISO | RGD:736461 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ALOX5AP mRNA | CTD | PMID:16931933 | kainic acid | increases expression | ISO | RGD:2097 | 6480464 | Kainic Acid results in increased expression of ALOX5AP mRNA | CTD | PMID:19700661 | L-methionine | multiple interactions | ISO | RGD:736461 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ALOX5AP mRNA | CTD | PMID:20938992 | lamivudine | multiple interactions | ISO | RGD:736461 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of ALOX5AP mRNA; more ... | CTD | PMID:16931933 | leukotriene B4 | multiple interactions | EXP | | 6480464 | ALOX5AP protein results in increased susceptibility to [Histamine results in increased abundance of Leukotriene B4]; more ... | CTD | PMID:9609743 | leukotriene C4 | multiple interactions | EXP | | 6480464 | [2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid results in decreased activity of ALOX5AP protein] which results in decreased abundance of Leukotriene C4; more ... | CTD | PMID:9113110 | nickel sulfate | decreases expression | EXP | | 6480464 | nickel sulfate results in decreased expression of ALOX5AP mRNA | CTD | PMID:16780908 | paracetamol | affects expression | ISO | RGD:736461 | 6480464 | Acetaminophen affects the expression of ALOX5AP mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | RGD:2097 | 6480464 | Acetaminophen results in decreased expression of ALOX5AP mRNA | CTD | PMID:19784758 | paracetamol | affects expression | ISO | RGD:2097 | 6480464 | Acetaminophen affects the expression of ALOX5AP mRNA | CTD | PMID:19784758 | paracetamol | increases expression | ISO | RGD:2097 | 6480464 | Acetaminophen results in increased expression of ALOX5AP mRNA | CTD | PMID:19784758 | parathion | decreases expression | ISO | RGD:2097 | 6480464 | Parathion results in decreased expression of ALOX5AP mRNA | CTD | PMID:19784758 | phenobarbital | multiple interactions | ISO | RGD:736461 | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in decreased expression of ALOX5AP mRNA] | CTD | PMID:19482888 | phenobarbital | decreases expression | ISO | RGD:736461 | 6480464 | Phenobarbital results in decreased expression of ALOX5AP mRNA | CTD | PMID:19482888 | pirinixic acid | decreases expression | ISO | RGD:736461 | 6480464 | pirinixic acid results in decreased expression of ALOX5AP mRNA | CTD | PMID:17426115 | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of ALOX5AP mRNA | CTD | PMID:21632981 | saquinavir | multiple interactions | ISO | RGD:736461 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA | CTD | PMID:16931933 | silicon dioxide | increases expression | ISO | RGD:2097 | 6480464 | Silicon Dioxide results in increased expression of ALOX5AP mRNA | CTD | PMID:21602193 | simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of ALOX5AP mRNA | CTD | PMID:17183729 | tamibarotene | increases expression | EXP | | 6480464 | Am 80 results in increased expression of ALOX5AP mRNA; more ... | CTD | PMID:15498508 | tamoxifen | affects expression | ISO | RGD:736461 | 6480464 | Tamoxifen affects the expression of ALOX5AP mRNA | CTD | PMID:17555576 | tetrachloromethane | affects expression | ISO | RGD:2097 | 6480464 | Carbon Tetrachloride affects the expression of ALOX5AP mRNA | CTD | PMID:12734012 | tetrachloromethane | decreases expression | ISO | RGD:2097 | 6480464 | Carbon Tetrachloride results in decreased expression of ALOX5AP mRNA | CTD | PMID:16644059 PMID:19784758 | tetrachloromethane | multiple interactions | ISO | RGD:2097 | 6480464 | 2-(4-(quinolin-2-yl-methoxy)phenyl)-2-cyclopentylacetic acid inhibits the reaction [Carbon Tetrachloride results in increased expression of ALOX5AP protein] | CTD | PMID:16033810 | tetrachloromethane | decreases expression | ISO | RGD:2097 | 6480464 | Carbon Tetrachloride results in decreased expression of ALOX5AP mRNA | CTD | PMID:19784758 PMID:16644059 | tetrachloromethane | increases expression | ISO | RGD:2097 | 6480464 | Carbon Tetrachloride results in increased expression of ALOX5AP protein | CTD | PMID:16033810 | tetracycline | decreases expression | ISO | RGD:736461 | 6480464 | Tetracycline results in decreased expression of ALOX5AP mRNA | CTD | PMID:16917069 | thioacetamide | decreases expression | ISO | RGD:2097 | 6480464 | Thioacetamide results in decreased expression of ALOX5AP mRNA | CTD | PMID:19784758 | zidovudine | multiple interactions | ISO | RGD:736461 | 6480464 | [Zidovudine co-treated with Lamivudine co-treated with Saquinavir] results in increased expression of ALOX5AP mRNA; more ... | CTD | PMID:16931933 | zoledronic acid | increases expression | EXP | | 6480464 | zoledronic acid results in increased expression of ALOX5AP mRNA | CTD | PMID:20977926 | | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Gene Ontology Annotations
Molecular Pathway Annotations
Disease Annotations
|
|
|
Gene-Chemical Interaction Annotations
|
|
|
Gene Ontology Annotations
|
|
|
|
|
Molecular Pathway Annotations
References - curated| 1. |
Back M, etal., Circ Res. 2007 Apr 13;100(7):946-9. Epub 2007 Mar 22. |
| 2. |
Becker KG, etal., Nat Genet 2004 May;36(5):431-2. |
| 3. |
Chu SJ, etal., J Immunol. 2000 Oct 15;165(8):4640-8. |
| 4. |
Dixon RA, etal., Nature 1990 Jan 18;343(6255):282-4. |
| 5. |
Escoubet-Lozach L, etal., Clin Exp Allergy 2001 Jul;31(7):1094-104. |
| 6. |
Fortunato G, etal., Arterioscler Thromb Vasc Biol. 2008 Mar;28(3):594-600. Epub 2008 Feb 7. |
| 7. |
Gibson CS, etal., Pediatrics. 2008 Nov;122(5):1079-85. |
| 8. |
GOA_HUMAN data from the GO Consortium |
| 9. |
Helgadottir A, etal., Nat Genet. 2004 Mar;36(3):233-9. Epub 2004 Feb 8. |
| 10. |
Henderson WR Jr, etal., J Exp Med. 1996 Oct 1;184(4):1483-94. |
| 11. |
Holloway JW, etal., Allergy. 2008 Aug;63(8):1046-53. Epub 2008 Jun 10. |
| 12. |
Hosford GE, etal., Exp Lung Res. 2002 Dec;28(8):671-84. |
| 13. |
Jame AJ, etal., Clin Exp Allergy. 2007 Jun;37(6):880-92. |
| 14. |
Kedda MA, etal., Clin Exp Allergy. 2005 Mar;35(3):332-8. |
| 15. |
Koshino T, etal., Biochem Biophys Res Commun. 1998 Jun 18;247(2):510-3. |
| 16. |
Koshino T, etal., Mol Cell Biol Res Commun. 1999 Jul;2(1):32-5. |
| 17. |
Lee HJ, etal., Radiat Res. 2008 Nov;170(5):579-90. |
| 18. |
Lemaitre RN, etal., Atherosclerosis. 2009 Jun;204(2):e58-63. Epub 2008 Nov 1. |
| 19. |
Liu J, etal., Hum Genet. 2009 Jun;125(5-6):649-56. Epub 2009 Apr 17. |
| 20. |
Lorrain DS, etal., J Pharmacol Exp Ther. 2009 Dec;331(3):1042-50. Epub 2009 Sep 11. |
| 21. |
Montero A, etal., J Nephrol. 2003 Sep-Oct;16(5):682-90. |
| 22. |
Patel N, etal., Blood. 2009 Jan 29;113(5):1129-38. Epub 2008 Oct 22. |
| 23. |
RGD automated import pipeline for gene-chemical interactions |
| 24. |
RGD Automated Pipelines |
| 25. |
Sayers I, etal., Clin Exp Allergy. 2003 Aug;33(8):1103-10. |
| 26. |
Seymour ML, etal., J Infect Dis. 2002 Feb 15;185(4):540-4. Epub 2002 Jan 31. |
| 27. |
Stanke-Labesque F, etal., J Allergy Clin Immunol. 2009 Aug;124(2):364-70, 370.e1-2. Epub 2009 Jul 12. |
| 28. |
Sveinbjornsson B, etal., FASEB J. 2008 Oct;22(10):3525-36. Epub 2008 Jun 30. |
| 29. |
Torres-Galvan SM, etal., J Investig Allergol Clin Immunol. 2009;19(6):453-8. |
| 30. |
Tsai AK, etal., Atherosclerosis. 2009 Jun 18. |
| 31. |
Via M, etal., Clin Exp Allergy. 2010 Apr;40(4):582-9. Epub 2010 Jan 11. |
| 32. |
Voelkel NF, etal., J Clin Invest 1996 Jun 1;97(11):2491-8. |
| 33. |
Wang J, etal., Cancer Epidemiol Biomarkers Prev. 2008 Oct;17(10):2748-54. |
| 34. |
Westergren VS, etal., Clin Exp Allergy. 2009 Jun;39(6):820-8. Epub 2009 Apr 2. |
| 35. |
Wright L, etal., Am J Respir Crit Care Med. 1998 Jan;157(1):219-29. |
| 36. |
Xu XW, etal., Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2007 Oct;24(5):491-4. |
| 37. |
Yamada Y, etal., Int J Mol Med. 2008 Jun;21(6):801-8. |
| 38. |
Yoshida T, etal., Int J Mol Med. 2009 Apr;23(4):529-37. |
References - uncurated| PubMed | 10036194 |
| 11090070 | |
| 12477932 | |
| 12571239 | |
| 12629151 | |
| 14702425 | |
| 14749922 | |
| 15057823 | |
| 15489334 | |
| 15593193 | |
| 15640973 | |
| 15731479 | |
| 15861005 | |
| 15876305 | |
| 15886380 | |
| 1588922 | |
| 16127181 | |
| 16144515 | |
| 16282974 | |
| 1673682 | |
| 16778124 | |
| 16939001 | |
| 17304054 | |
| 17387518 | |
| 17460547 | |
| 17505527 | |
| 17600184 | |
| 17627106 | |
| 17655870 | |
| 18084092 | |
| 18318662 | |
| 18323512 | |
| 18366797 | |
| 18369664 | |
| 18374923 | |
| 18398223 | |
| 18398440 | |
| 1857337 | |
| 18775537 | |
| 19126581 | |
| 19130089 | |
| 19131661 | |
| 19166692 | |
| 19233132 | |
| 19336475 | |
| 19361804 | |
| 19417766 | |
| 19423540 | |
| 19450127 | |
| 19524426 | |
| 19622707 | |
| 19729601 | |
| 19948975 | |
| 20014490 | |
| 20194722 | |
| 20357438 | |
| 20369037 | |
| 20376802 | |
| 20379614 | |
| 20406964 | |
| 20438785 | |
| 20485444 | |
| 20592751 | |
| 20810156 | |
| 21153769 | |
| 21199733 | |
| 21227888 | |
| 21675249 | |
| 21816595 | |
| 21893978 | |
| 22051033 | |
| 22074807 | |
| 22129473 | |
| 22206291 | |
| 22537113 | |
| 22726381 | |
| 22849376 | |
| 7938075 | |
| 8049076 | |
| 8071328 | |
| 8245774 | |
| 8440384 | |
| 8703034 | |
| 8777565 | |
| 9435249 |
RGD Disease Portals| ALOX5AP has been annotated in the following RGD Disease Portals. |
|||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
![]() |
| ||||||
Comparative Map Data| ALOX5AP (Homo sapiens) |
|
|||||||||||||||||||||||||||||||||||
| Alox5ap (Mus musculus) |
|
|||||||||||||||||||||||||||||||||||
| Alox5ap (Rattus norvegicus) |
|
Position Markers| RH121762 |
|
|||||||||||||||||||||||||||||||||||
| SHGC-142275 |
|
|||||||||||||||||||||||||||||||||||
| SHGC-149049 |
|
|||||||||||||||||||||||||||||||||||
| D13S1772 |
|
|||||||||||||||||||||||||||||||||||
| D13S1800 |
|
QTLs in Region (Human Genome Assembly GRCh37)| The following QTLs overlap with this region. | ![]() | Full Report | ![]() | CSV | ![]() | TAB | ![]() | Printer | ![]() | Gviewer |
Nucleotide Sequences| Nucleotide RefSeqs | NG_011963 | (Get FASTA) | Search GEO for Microarray Profiles |
| NM_001204406 | (Get FASTA) | Search GEO for Microarray Profiles | |
| NM_001629 | (Get FASTA) | Search GEO for Microarray Profiles | |
| GenBank Nucleotide | ABBA01035689 | (Get FASTA) | Search GEO for Microarray Profiles |
| AK314143 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AL512642 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AMYH01005011 | (Get FASTA) | Search GEO for Microarray Profiles | |
| AY619687 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BC018538 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BG569867 | (Get FASTA) | Search GEO for Microarray Profiles | |
| BQ003388 | (Get FASTA) | Search GEO for Microarray Profiles | |
| CH471075 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M60470 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M63259 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M63260 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M63261 | (Get FASTA) | Search GEO for Microarray Profiles | |
| M63262 | (Get FASTA) | Search GEO for Microarray Profiles |
| RefSeq Acc Id: | NM_001204406 | ||||||||||||||||||||
| RefSeq Status: | REVIEWED | ||||||||||||||||||||
| Type: | CODING | ||||||||||||||||||||
| Protein Acc Id: | NP_001191335 | ||||||||||||||||||||
| Peptide Label: | isoform 2 | ||||||||||||||||||||
| Position: |
|
| RefSeq Acc Id: | NM_001629 | |||||||||||||||||||||||||
| RefSeq Status: | REVIEWED | |||||||||||||||||||||||||
| Type: | CODING | |||||||||||||||||||||||||
| Protein Acc Id: | NP_001620 | |||||||||||||||||||||||||
| Peptide Label: | isoform 1 | |||||||||||||||||||||||||
| Position: |
|
Protein Sequences| Protein RefSeqs | NP_001191335 | (Get FASTA) |
| NP_001620 | (Get FASTA) | |
| GenBank Protein | AAA35845 | (Get FASTA) |
| AAH18538 | (Get FASTA) | |
| AAT38104 | (Get FASTA) | |
| ABM82573 | (Get FASTA) | |
| ABM85762 | (Get FASTA) | |
| EAX08467 | (Get FASTA) | |
| P20292 | (Get FASTA) |
Promoters| RGD ID: | 6865968 | ||||||||||
| Promoter ID: | EPDNEW_H6149 | ||||||||||
| Type: | initiation region | ||||||||||
| Name: | SH3BP2_6 | ||||||||||
| Description: | SH3-domain binding protein 2 | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/) | ||||||||||
| Position: |
|
| RGD ID: | 6790700 | ||||||||||
| Promoter ID: | HG_KWN:17448 | ||||||||||
| Type: | Non-CpG | ||||||||||
| SO ACC ID: | SO:0000170 | ||||||||||
| Source: | MPROMDB | ||||||||||
| Tissues & Cell Lines: | CD4+TCell_2Hour, K562, Lymphoblastoid | ||||||||||
| Transcripts: | OTTHUMT00000044372 | ||||||||||
| Position: |
|
External Database Links| Database | Acc Id | Source(s) |
| COSMIC | ALOX5AP | COSMIC |
| Ensembl Genes | ENSG00000132965 | ENTREZGENE |
| Ensembl Protein | ENSP00000369858 | ENTREZGENE |
| Ensembl Transcript | ENST00000380490 | ENTREZGENE |
| Entrez Gene | 241 | ENTREZGENE |
| Gene3D-CATH | G3DSA:1.20.120.550 | UniProtKB/Swiss-Prot |
| Germonline | ENSG00000132965 | |
| HGNC ID | 436 | ENTREZGENE |
| HomoloGene Group ID | 1231 | ENTREZGENE |
| HPRD ID | 04742 | ENTREZGENE |
| InterPro | 5_LipOase_AP | UniProtKB/Swiss-Prot |
| FLAP/GST2/LTC4S_CS | UniProtKB/Swiss-Prot | |
| MAPEG-like_dom | UniProtKB/Swiss-Prot | |
| Membr-assoc_MAPEG | UniProtKB/Swiss-Prot | |
| IPI | IPI00022975 | UniProtKB/Swiss-Prot |
| KEGG Report | hsa:241 | ENTREZGENE, UniProtKB/Swiss-Prot |
| OMIM | 601367 | OMIM |
| 603700 | OMIM | |
| Pfam | MAPEG | UniProtKB/Swiss-Prot |
| PharmGKB | PA47 | PharmGKB |
| PRINTS | 5LPOXGNASEAP | UniProtKB/Swiss-Prot |
| PROSITE | FLAP_GST2_LTC4S | UniProtKB/Swiss-Prot |
| UniGene | Hs.507658 | ENTREZGENE |
| UniProt | AL5AP_HUMAN | UniProtKB/Swiss-Prot |
Nomenclature History| Date | Current Symbol | Current Name | Previous Symbol | Previous Name | Description | Reference | Status |
|---|---|---|---|---|---|---|---|
| 2011-08-16 | ALOX5AP | arachidonate 5-lipoxygenase-activating protein | ALOX5AP | arachidonate 5-lipoxygenase-activating protein | Symbol and/or name change | 39860 | APPROVED |
| 2011-07-27 | ALOX5AP | arachidonate 5-lipoxygenase-activating protein | ALOX5AP | arachidonate 5-lipoxygenase-activating protein | Symbol and/or name change | 39860 | APPROVED |
| More on ALOX5AP | |||
![]() |
Entrez Gene | ||
![]() |
Ensembl Gene | ||
|
|
||
![]() |
HGNC Report | ||
![]() |
NCBI Map Viewer | ||
![]() |
Vista | ||
![]() |
Vista + UCSC | ||
| RGD Object Information | |
| RGD ID: | 736460 |
| Created: | 2004-02-06 |
| Species: | Homo sapiens |
| Last Modified: | 2013-03-06 |
| Status: | ACTIVE |
© Bioinformatics Program, HMGC at the Medical College of Wisconsin
RGD is funded by grant HL64541 from the National Heart, Lung, and Blood Institute on behalf of the NIH.




